emocha was created by clinicians and scientists at Johns Hopkins, and first deployed in rural Uganda. Since spinning out of Johns Hopkins in 2014, we’ve tackled dozens of public health challenges head-on. We’ve fought the most pressing health challenges of our time through better medication adherence management: asthma, diabetes, COPD, hypertension, sickle cell disease, tuberculosis, HIV, hepatitis C, solid organ transplant, depression, and substance use disorders. To every challenge, we said yes. Game on. We’re all in.
emocha was created by clinicians and scientists at Johns Hopkins, and first deployed in rural Uganda. Since spinning out of Johns Hopkins in 2014, we’ve tackled dozens of public health challenges head-on. We’ve fought the most pressing health challenges of our time through better medication adherence management: asthma, diabetes, COPD, hypertension, sickle cell disease, tuberculosis, HIV, hepatitis C, solid organ transplant, depression, and substance use disorders. To every challenge, we said yes. Game on. We’re all in.
emocha was created by clinicians and scientists at Johns Hopkins, and first deployed in rural Uganda. Since spinning out of Johns Hopkins in 2014, we’ve tackled dozens of public health challenges head-on. We’ve fought the most pressing health challenges of our time through better medication adherence management: asthma, diabetes, COPD, hypertension, sickle cell disease, tuberculosis, HIV, hepatitis C, solid organ transplant, depression, and substance use disorders. To every challenge, we said yes. Game on. We’re all in.
emocha was created by clinicians and scientists at Johns Hopkins, and first deployed in rural Uganda. Since spinning out of Johns Hopkins in 2014, we’ve tackled dozens of public health challenges head-on. We’ve fought the most pressing health challenges of our time through better medication adherence management: asthma, diabetes, COPD, hypertension, sickle cell disease, tuberculosis, HIV, hepatitis C, solid organ transplant, depression, and substance use disorders. To every challenge, we said yes. Game on. We’re all in.